[MFDS News] [Press Release] MFDS, Published English Assessment Summaries of Locally Developed Biosimilars

                                   

[Press Release] MFDS, Published English Assessment Summaries of Locally Developed Biosimilars

- Two Home-grown Lucentis Biosimilars Added to List of English Assessment Summaries of MFDS-approved Biosimilars

The Ministry of Food and Drug Safety (Minister OH Yu-Kyoung) announced that the English assessment summary information of two Korean Lucentis biosimilars (ranibizumab)* to treat age-related macular degeneration was disclosed at the MFDS website.

* Amelivu inj. (Samsung Bioepis), Chong Kun Dang Ranibizumab inj. (Chong Kun Dang)

By - MFDS